All In Biotech

Free tool

FAERS Monitor: Monodox

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050641 or its brand name (Monodox, Doxycycline). Reports on generic versions are filed under their own applications.

Reports

53,422

Serious

41,375

77% of reports

Hospitalization

18,296

Death reported

4,956

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,220
  • off label use3,727
  • nausea3,691
  • fatigue3,327
  • dyspnoea3,154
  • rash3,090
  • diarrhoea3,040
  • headache2,878
  • pain2,867
  • vomiting2,840
  • malaise2,385
  • condition aggravated2,196
  • chronic kidney disease2,158
  • pyrexia2,139
  • arthralgia2,097

Reports by year received

View as table
YearReports
2004221
2005316
2006318
2007351
2008418
2009681
2010930
20111,144
20121,301
20131,415
20141,657
20152,028
20162,664
20172,772
20183,495
20194,345
20204,138
20213,627
20223,919
20234,687
20244,930
20254,749
20263,316

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,737 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal2,15811.511.020,121
condition aggravatedSignal2,1962.92.72,668
rashSignal3,0902.82.73,634
pyrexiaSignal2,1392.42.31,840
vomitingSignal2,8402.42.32,325
dyspnoeaSignal3,1542.22.12,109
malaiseSignal2,3852.12.11,484
arthralgia2,0972.01.91,048
diarrhoea3,0401.91.81,236
pain2,8671.81.81,129
nausea3,6911.81.81,463
headache2,8781.81.71,072
fatigue3,3271.71.6958
off label use3,7271.71.61,062
drug ineffective4,2201.31.2243

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.